The global breast imaging market is on an upward trajectory, projected to reach USD 6.6 billion by 2028 from USD 4.4 billion in 2023. This represents a notable CAGR of 8.5% during the forecast period of 2023-2028. A recent report, titled "Breast Imaging Market by Technology (Ionizing, Non-ionizing), Product (Breast Imaging Systems, Software and Services, Accessories), End User (Hospitals and Clinics, Diagnostic Imaging Centers, Breast Care Centers) - Global Forecasts to 2028" sheds light on this booming sector. Let's delve into the key factors driving this growth and the market landscape.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=897

The report reveals that rising awareness campaigns, increasing public-private investments, and lucrative opportunities in emerging markets are the major factors propelling the growth of the breast imaging market. Additionally, the increasing incidence of breast cancer and the growing emphasis on early detection and diagnosis are fueling market growth.

Non-Ionizing Breast Imaging Technologies: A Growth Frontier

The breast imaging market is segmented into ionizing and non-ionizing breast imaging technologies. While ionizing breast imaging technologies have dominated the market, non-ionizing breast imaging technologies are anticipated to register significant growth during the forecast period. Factors such as safety, reduced radiation exposure, and technological advancements are driving the adoption of non-ionizing breast imaging technologies.

Software & Services: Leading the Market

In terms of products, the breast imaging market comprises breast imaging systems, software & services, and accessories. The software & services segment held the largest market share in 2022 and is expected to grow at the highest CAGR during the forecast period. The rising installation of breast imaging systems in various healthcare facilities and the introduction of novel software are key factors contributing to the growth of this segment.

Hospitals and Clinics: Key End Users

End-user segments include hospitals and clinics, diagnostic imaging centers, breast care centers, and others. Hospitals and clinics accounted for the largest share of the breast imaging market in 2022. The consistent adoption of advanced imaging instruments for early detection of breast cancer is driving the growth of this segment.

Asia Pacific: A Lucrative Market

The Asia Pacific region is expected to witness the highest growth in the breast imaging market from 2023 to 2028. Major market players are expanding their manufacturing capabilities in the APAC region to capitalize on the growing demand for advanced breast imaging technologies. The rising adoption of high-end equipment in countries like China, India, and Japan offers significant growth opportunities for key players.

Key Players Shaping the Market

As of 2022, prominent players in the breast imaging market include GE Healthcare (US), Hologic, Inc. (US), Siemens Healthcare GmbH (Germany), Koninklijke Philips N.V. (Netherlands), and FUJIFILM Holdings Corporation (Japan). These players are focusing on strategic initiatives such as product launches, partnerships, and acquisitions to strengthen their market position and expand their product portfolios.

Request Free Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=897

In conclusion, with increasing investments in healthcare infrastructure, technological advancements, and growing awareness about breast health, the breast imaging market is poised for substantial growth in the coming years.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]